| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Clinical Research Centers |
Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, Childrens Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania 15213
Address all correspondence and requests for reprints to: Silva A. Arslanian, M.D., Division of Endocrinology, Childrens Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, Pennsylvania 15213. E-mail: arslans{at}chplink.chp.edu
Serum leptin levels reflect the amount of body fat. However, several reports suggest that insulin may also regulate serum leptin levels. This study was aimed at testing whether leptin levels are low in newly diagnosed patients with type 1 diabetes and increase after institution of insulin therapy. Nineteen children with new-onset type 1 diabetes were studied. Serum leptin levels were measured at presentation before insulin therapy was initiated (day 0), 1 day after insulin therapy (day 1), 35 days after insulin therapy (day 35), and at 3 months of follow-up (3 months). The control group consisted of 19 healthy children matched for age and body mass index.
On day 0 leptin levels were lower in the patients compared with those in controls (3.3 ± 0.2 vs. 6.2 ± 0.9 ng/mL; P < 0.005). After insulin therapy, leptin levels increased significantly by day 1 without significant weight change and became comparable to control values by days 35. Before insulin therapy, leptin did not correlate with weight, body mass index, or hemoglobin A1c. After insulin therapy, leptin levels on days 35 correlated with insulin dose (r = 0.43; P = 0.03). The results of this study demonstrate that children with new-onset type 1 diabetes have low leptin levels before insulin therapy. Leptin levels increase within 24 h of insulin therapy and become comparable to nondiabetic levels by 35 days. This rapid increase in leptin after 24 h of insulinization is independent of changes in body weight and is postulated to be due to a stimulatory effect of insulin on leptin production, nutritional replenishment, or both factors together.
This article has been cited by other articles:
![]() |
A.-M. Aas, K. F. Hanssen, J. P. Berg, P. M. Thorsby, and K. I. Birkeland Insulin-Stimulated Increase in Serum Leptin Levels Precedes and Correlates with Weight Gain during Insulin Therapy in Type 2 Diabetes J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2900 - 2906. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Kratzsch, I Knerr, A Galler, T Kapellen, K Raile, A Korner, J Thiery, J Dotsch, and W Kiess Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor. Eur. J. Endocrinol., October 1, 2006; 155(4): 609 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Targher, L. Zenari, G. Faccini, G. Falezza, M. Muggeo, and G. Zoppini Serum Leptin Concentrations in Young Smokers With Type 1 Diabetes Diabetes Care, April 1, 2001; 24(4): 793 - 794. [Full Text] |
||||
![]() |
V. Y. POLOTSKY, J. A. WILSON, A. S. HAINES, M. T. SCHARF, S. E. SOUTIERE, C. G. TANKERSLEY, P. L. SMITH, A. R. SCHWARTZ, and C. P. O'DONNELL The Impact of Insulin-Dependent Diabetes on Ventilatory Control in the Mouse Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 624 - 632. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |